---

Healing and Scarring — Robbins & Cotran Pathology (Explained Simply)

---

The Big Picture First

---

Part 1: Cell Proliferation Capacity (Who Can Regenerate?)

🟢 Labile (Continuously Dividing) Cells

• Always dividing, always replacing themselves
• Examples: skin epithelium, gut lining, bone marrow blood cells, oral/esophageal/cervical epithelia
• These regenerate very easily after injury

🟡 Stable (Quiescent) Cells

• Normally dormant (not dividing), but can divide when needed
• Examples: liver cells (hepatocytes), kidney tubular cells, smooth muscle, endothelial cells, fibroblasts
• They wake up and proliferate when injured — this is why the liver can regenerate after partial removal

🔴 Permanent (Non-Dividing) Cells

• Lost forever once destroyed — they cannot divide
• Examples: neurons, cardiac muscle cells (cardiomyocytes), skeletal muscle cells
• Injury here almost always leads to scarring, not regeneration

---

Part 2: What Drives Regeneration? (Growth Factors & ECM)

• Provides a "highway" for migrating cells
• Stores growth factors, releasing them when tissue is damaged
• Signals cells when to stop or start dividing

Think of ECM as the building's scaffolding — without it, even cells that want to regenerate don't know where to go.

---

Part 3: Repair by Scarring — Steps in Scar Formation

Step 1 — Angiogenesis (New Blood Vessels Grow In)

• New capillaries sprout into the wound
• Driven by VEGF and FGF
• These vessels are leaky and bring nutrients and inflammatory cells to the repair zone

Step 2 — Migration and Proliferation of Fibroblasts

• Fibroblasts are connective tissue cells that produce collagen
• They are recruited from the wound margins and surrounding tissue by PDGF and FGF
• They migrate into the wound and start multiplying
• Macrophages are crucial here — they secrete growth factors (PDGF, TGF-β, FGF) that keep the process going

Step 3 — Granulation Tissue Formation

Granulation tissue = new capillaries + proliferating fibroblasts + macrophages + loose ECM

• Appears as soft, pink, granular tissue (hence the name)
• Fills the wound space
• Is very vascular (bleeds easily when touched)
• Is the "raw material" from which the scar is built

Step 4 — Remodelling (Scar Maturation)

• Fibroblasts lay down collagen (mainly Type III early → replaced by Type I later)
• Blood vessels regress (the scar becomes avascular and pale)
• Myofibroblasts (fibroblasts with contractile properties, like muscle) cause wound contraction — this physically pulls the wound edges together
• The scar shrinks and hardens over weeks to months
• Net result: a pale, firm, avascular scar

Think of it like wet cement drying — first soft and pliable, then it hardens and shrinks.

---

Part 4: Healing of Skin Wounds

Primary Intention (Clean Surgical Wound — edges close together)

1. Clot forms between the edges
2. Inflammatory cells clean up debris (24–48 hrs)
3. Epithelial cells migrate across the narrow gap within 24–48 hrs
4. Granulation tissue forms by day 3–5
5. Scar forms — small and neat
6. Wound strength reaches ~70–80% of normal by 3 months

Secondary Intention (Large wound — edges far apart)

• Much more granulation tissue needed to fill the gap
• Wound contraction by myofibroblasts is very prominent (can reduce wound size by up to 80%)
• Larger, more unsightly scar
• Takes much longer to complete

---

Part 5: Factors That Affect Healing

Local Factors

Systemic Factors

---

Part 6: Abnormalities in Healing

Chronic Wounds (Defects in Healing)

• Persistent infection
• Ischaemia (poor blood supply)
• Diabetes
• Sustained pressure (pressure sores)

Excessive Scarring (Too Much of a Good Thing)

---

Summary Flow Chart (Simplified)

INJURY
  │
  ├─── Mild (epithelium only)
  │         └── Stem cells proliferate → REGENERATION → Normal tissue
  │
  └─── Severe (connective tissue damaged)
            └── Angiogenesis → Fibroblast recruitment
                    └── GRANULATION TISSUE forms
                            └── Collagen deposited, vessels regress, myofibroblasts contract
                                    └── MATURE SCAR (pale, firm, avascular)

---

---

Anemia — Detailed MS1 Outline

Robbins, Cotran & Kumar — Pathologic Basis of Disease | Guyton & Hall — Medical Physiology

---

SECTION 1: DEFINITION & OVERVIEW

• ↓ Hematocrit (packed RBC volume / total blood volume)
• ↓ Hemoglobin concentration (g/dL)

"Anemia means deficiency of hemoglobin in the blood, which can be caused by too few RBCs or too little hemoglobin in the cells." — Guyton & Hall

---

SECTION 2: CLASSIFICATION

2A. By Mechanism (Robbins — Table 14.1)

2B. By Morphology (Peripheral Smear — Clinically Useful)

Key Red Cell Indices (MS1 must know)

---

SECTION 3: HEMOLYTIC ANEMIAS (Increased Destruction)

Key concept: Hemolysis = RBC destruction before their normal 120-day lifespan. Can be intravascular (within blood vessels) or extravascular (in spleen/liver macrophages — most common).

• ↓ Hb, ↓ Hematocrit
• ↑ Reticulocytes (compensatory bone marrow response)
• ↑ Unconjugated (indirect) bilirubin → jaundice
• ↑ LDH (cell lysis)
• ↓ Haptoglobin (binds free Hb — consumed)
• Splenomegaly (from RBC trapping)

---

3A. HEREDITARY SPHEROCYTOSIS (HS)

Pathogenesis

• Autosomal dominant (AD) in most; some autosomal recessive (AR)
• Defect: Mutations in genes encoding RBC cytoskeletal proteins:
  • Ankyrin (most common)
  • Spectrin (α or β)
  • Band 3 protein
  • Protein 4.2
• These proteins anchor the lipid bilayer to the cytoskeleton
• Deficiency → membrane instability → RBC loses membrane fragments (vesiculation) as it squeezes through tight capillaries
• Surface area decreases relative to volume → sphere shape (spherocyte) instead of biconcave disc
• Spherocytes are rigid — cannot deform and get trapped in splenic sinusoids
• Repeated trapping → further membrane loss → eventually destroyed by splenic macrophages = extravascular hemolysis

"The RBCs are very small and spherical rather than being biconcave discs. These cells cannot withstand compression forces because they do not have the normal loose, baglike cell membrane structure of the biconcave discs." — Guyton & Hall

Peripheral Smear

• Small, round, dark-staining spherocytes — no central pallor
• ↑ Reticulocytes

Diagnosis

• Osmotic fragility test — spherocytes lyse in hypotonic saline more readily than normal RBCs
• Flow cytometry (EMA binding test) — modern, more sensitive
• Negative direct Coombs (distinguishes from autoimmune HA)

Clinical Features

• Anemia (variable severity)
• Jaundice (unconjugated bilirubin)
• Splenomegaly (from RBC trapping — can be massive)
• Pigment gallstones (from excess bilirubin → calcium bilirubinate stones)
• Aplastic crisis — triggered by Parvovirus B19 infection (kills erythroid precursors → sudden worsening of anemia)
• Megaloblastic crisis — if folate demand overwhelms supply

Treatment

• Splenectomy — removes the site of destruction → cures anemia (but spherocytes persist on smear)
• Folic acid supplementation
• Monitor for aplastic crises

---

3B. G6PD DEFICIENCY (Glucose-6-Phosphate Dehydrogenase Deficiency)

Pathogenesis

• X-linked recessive → mainly affects males; females can be carriers (heterozygous females may be mildly affected)
• G6PD is the first enzyme of the pentose phosphate pathway (HMP shunt)
• Its job: produce NADPH → keeps glutathione in its reduced form (GSH)
• GSH is the RBC's primary antioxidant — it neutralizes oxidative radicals (H₂O₂, superoxide)
• Without adequate G6PD → GSH depleted → oxidative stress cannot be countered
• Oxidized hemoglobin denatures → forms Heinz bodies (precipitates stuck to RBC membrane)
• RBCs with Heinz bodies are partially phagocytosed by splenic macrophages → "bite cells" (blister cells) on smear
• Eventually → episodic hemolysis, triggered by oxidative stressors

Triggers of Hemolytic Episodes

Types of G6PD Variants

Peripheral Smear During Crisis

• Heinz bodies (visible with crystal violet stain — not standard H&E)
• Bite cells / blister cells (macrophages "bite out" Heinz bodies)
• Polychromasia (reticulocytosis)

Diagnosis

• G6PD enzyme assay (best done after crisis — during crisis, old deficient cells are destroyed and only young cells with higher enzyme levels remain → may give false normal)
• Heinz body preparation

Clinical Features

• Between episodes: Normal (no anemia, no symptoms)
• During episode: Acute onset hemolytic anemia with dark urine (hemoglobinuria), jaundice, back/abdominal pain, fatigue
• Self-limiting in G6PD A− (bone marrow compensates as new young RBCs replace old ones)
• More severe in Mediterranean variant

Treatment

• Avoid triggers
• Supportive care during crisis (transfusion if severe)
• No specific cure (no splenectomy benefit)

---

3C. SICKLE CELL DISEASE (SCD)

Molecular Basis

• Autosomal recessive (codominant)
• Single point mutation in the β-globin gene (chromosome 11): → Glutamic acid (position 6) replaced by Valine → Normal HbA (α₂β₂) → HbS (α₂β^S₂)
• HbSS = sickle cell disease (homozygous, severe)
• HbAS = sickle cell trait (heterozygous, usually asymptomatic, protective against P. falciparum malaria)

Mechanism of Sickling

1. Deoxygenation → HbS polymerizes into long rigid tactoids (fibers)
2. RBC is distorted into a sickle/crescent shape
3. Initially reversible (re-oxygenation → un-sickles); with repeated episodes → irreversibly sickled cells (membrane permanently damaged)
4. Sickled cells are:
   • Rigid → obstruct small vessels → vaso-occlusion (ischemia, infarction)
   • Fragile → destroyed by spleen → hemolysis

Factors that Promote Sickling

• ↓ O₂ tension (hypoxia)
• ↑ HbS concentration (dehydration)
• ↓ pH (acidosis)
• High altitude, cold, infection, strenuous exercise

"The precipitated hemoglobin also damages the cell membrane, so the cells become highly fragile, leading to serious anemia." — Guyton & Hall

Clinical Features (MS1 High-Yield)

• Chronic hemolytic anemia (Hb 6–9 g/dL)
• Jaundice, splenomegaly (early), pigment gallstones
• Aplastic crisis (Parvovirus B19)
• Hyperhemolytic crisis (triggered by infection)

• Delayed growth, susceptibility to infections (functional asplenia)
• "H-shaped" vertebrae on X-ray (vertebral body infarcts)

Peripheral Smear

• Sickle cells (crescent-shaped)
• Target cells
• Howell-Jolly bodies (after autosplenectomy — nuclear remnants in RBCs, normally removed by spleen)
• ↑ Reticulocytes

Diagnosis

• Hemoglobin electrophoresis (gold standard) — shows HbS band, absent HbA
• Sickling test (sodium metabisulfite) — induces sickling in vitro
• Newborn screening (HPLC)

Treatment

• Hydroxyurea — increases HbF (fetal hemoglobin) production → HbF inhibits HbS polymerization → ↓ crises
• Penicillin prophylaxis (to prevent infection in asplenic patients)
• Pneumococcal/meningococcal/H. flu vaccination
• Folic acid (for increased erythropoiesis)
• Exchange transfusion (acute chest syndrome, stroke)
• Bone marrow transplantation (curative, for severe cases)

---

3D. THALASSEMIA

---

β-Thalassemia

• β⁰ mutations → no β-chain produced
• β⁺ mutations → reduced β-chain produced
• Over 200 known mutations (mostly point mutations in splice sites, promoters)

• ↓ β-globin → excess α-globin chains accumulate
• Free α-chains precipitate → form inclusion bodies → damage RBC membrane
• → Ineffective erythropoiesis (precursors die in bone marrow before releasing)
• → Hemolysis of released RBCs (extravascular)
• Compensatory: massive erythropoiesis → bone marrow expansion → skeletal deformities

• Severe hemolytic anemia requiring transfusions from 6 months of age (when HbF → HbA switch occurs)
• Massive hepatosplenomegaly (extramedullary hematopoiesis)
• "Crew-cut" skull X-ray (expanded marrow — perpendicular trabeculae)
• Chipmunk facies (maxillary overgrowth from marrow expansion)
• Skeletal deformities
• Growth retardation
• Iron overload (from transfusions + increased GI absorption) → hemosiderosis → heart failure, cirrhosis, endocrine failure (diabetes, hypogonadism) → main cause of death
• ↑ HbF (compensatory), ↓ or absent HbA, ↑ HbA₂

• Regular blood transfusions (keep Hb > 9–10 g/dL)
• Iron chelation (deferoxamine, deferasirox) — essential to prevent iron overload
• Bone marrow transplantation (curative)
• Splenectomy (if hypersplenism worsens anemia)

---

α-Thalassemia

---

3E. IMMUNOHEMOLYTIC ANEMIA (Autoimmune Hemolytic Anemia, AIHA)

---

3F. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

• Acquired mutation in PIG-A gene → loss of GPI-anchor proteins (CD55, CD59)
• CD55 and CD59 normally protect RBCs from complement attack
• Without them → complement destroys RBCs → intravascular hemolysis
• Classic triad: hemolytic anemia + thrombosis (unusual sites: hepatic vein → Budd-Chiari) + cytopenias
• Hemoglobinuria worse in the morning (acidosis during sleep → complement activation)
• Diagnosis: Flow cytometry for loss of CD55/CD59
• Treatment: Eculizumab (anti-C5 complement inhibitor) — game-changer

---

SECTION 4: ANEMIAS OF DIMINISHED ERYTHROPOIESIS

4A. IRON DEFICIENCY ANEMIA

Iron Metabolism (Quick Review)

• Daily requirement: adult males 1 mg/day; menstruating females 2 mg/day; pregnancy 3 mg/day
• Absorbed in duodenum and proximal jejunum
• Stored as ferritin (soluble) and hemosiderin (insoluble) in liver, spleen, marrow
• Transported by transferrin (plasma)

Causes

⚠️ "An alert clinician investigating unexplained iron deficiency anemia occasionally discovers an occult bleeding source such as cancer and thereby saves a life." — Robbins & Cotran

Lab Findings

Stages of Iron Deficiency

1. Pre-latent: Iron stores depleted (↓ ferritin), no anemia yet
2. Latent: ↓ serum iron, ↑ TIBC, no anemia yet
3. Iron deficiency anemia: Microcytic hypochromic anemia appears

Clinical Features

• Fatigue, pallor, weakness, exertional dyspnea
• Pica — craving for non-food items (ice = pagophagia, clay = geophagia)
• Koilonychia (spoon-shaped nails)
• Angular stomatitis (cracking at corners of mouth)
• Atrophic glossitis (smooth tongue)
• Plummer-Vinson syndrome (iron deficiency + esophageal webs + dysphagia) — ↑ risk of esophageal cancer

Treatment

• Find and treat the underlying cause
• Oral iron (ferrous sulfate) for 3–6 months (continue 3 months after Hb normalizes to replenish stores)
• IV iron (if malabsorption, intolerance, severe)
• Reticulocyte response in 5–10 days confirms diagnosis

---

4B. MEGALOBLASTIC ANEMIA (B12 / Folate Deficiency)

Key Concept

"The RBCs grow too large, with odd shapes, and are called megaloblasts... the cells are mostly oversized, have bizarre shapes, and have fragile membranes." — Guyton & Hall

Vitamin B12 Deficiency

• Dietary B12 (animal products) → binds intrinsic factor (IF) (secreted by gastric parietal cells) → B12-IF complex absorbed in terminal ileum

• Autoimmune — anti-parietal cell antibodies (destroy parietal cells), anti-intrinsic factor antibodies (block B12-IF binding)
• Associated with other autoimmune diseases (Hashimoto's, T1DM)
• ↑ risk of gastric carcinoma

• Subacute combined degeneration of the spinal cord — degeneration of dorsal columns + lateral corticospinal tracts → loss of vibration sense, proprioception, upper motor neuron signs, peripheral neuropathy

Folate Deficiency

• Poor diet (alcoholics, elderly, overcooking vegetables)
• ↑ Demand (pregnancy, hemolytic anemia, rapid growth)
• Malabsorption (celiac, sprue)
• Drugs: Methotrexate, trimethoprim, phenytoin (folate antagonists)

⚠️ Folate in pregnancy: Deficiency → neural tube defects (spina bifida, anencephaly). Supplementation begun before conception.

Lab Findings (Both B12 and Folate)

Treatment

• B12 deficiency: IM cyanocobalamin (if pernicious anemia or malabsorption — oral is ineffective)
• Folate deficiency: Oral folic acid
• ⚠️ Never give folate alone if B12 deficiency suspected — corrects hematologic picture but neurological damage continues

---

4C. APLASTIC ANEMIA

Definition

Causes

"Exposure to high-dose radiation or chemotherapy for cancer treatment can damage stem cells of the bone marrow... toxic chemicals, such as insecticides or benzene..." — Guyton & Hall

Lab Findings

• Pancytopenia (↓ Hb, ↓ WBC, ↓ platelets)
• Hypocellular bone marrow with fatty replacement (> 70% fat on biopsy) — diagnostic
• ↓ Reticulocytes (production failure)
• Normal RBC morphology

Clinical Features

• Anemia symptoms (fatigue, pallor)
• Infections (neutropenia — most dangerous)
• Bleeding (thrombocytopenia — petechiae, ecchymoses)

Treatment

• Mild/moderate: Immunosuppression (anti-thymocyte globulin + cyclosporine + eltrombopag)
• Severe, young patient with matched donor: Bone marrow transplantation (curative)
• Supportive: transfusions, growth factors (G-CSF)

---

4D. ANEMIA OF CHRONIC DISEASE (ACD) / ANEMIA OF INFLAMMATION

Pathogenesis (Robbins)

• Chronic infections, autoimmune disease, cancer → chronic inflammation → ↑ hepcidin (made by liver, induced by IL-6)
• Hepcidin degrades ferroportin (the iron exporter on macrophages and gut enterocytes)
• Result: iron trapped in macrophage stores, ↓ iron absorption → functional iron deficiency (iron is there but can't be used)
• Also: ↓ erythropoietin response, ↓ RBC lifespan

Lab Findings

"Serum iron levels usually are low in the anemia of chronic disease, and the red cells may be slightly hypochromic and microcytic. In contrast to iron deficiency anemia, however, storage iron in the bone marrow and serum ferritin are increased." — Robbins & Cotran

Treatment

• Treat underlying disease
• Erythropoietin-stimulating agents (ESAs) in CKD
• IV iron (if also functionally iron-depleted)

---

SECTION 5: PHYSIOLOGICAL EFFECTS OF ANEMIA (Guyton & Hall)

Cardiovascular Compensation

• ↓ Blood viscosity → ↓ peripheral resistance → ↑ cardiac output (both ↑ HR and ↑ stroke volume)
• High-output state → can eventually cause heart failure in severe/chronic anemia
• Vasodilation (tissue hypoxia → local mediators)

Oxygen Delivery Compensation

• ↑ 2,3-BPG (DPG) in RBCs → right-shifts oxygen-hemoglobin dissociation curve → hemoglobin releases O₂ more readily to tissues
• Tissues extract more O₂ per unit of blood (↑ O₂ extraction fraction)

Erythropoietin Response

• Kidney peritubular cells sense ↓ O₂ → ↑ EPO secretion
• EPO → bone marrow → ↑ erythroid progenitor proliferation → ↑ reticulocytes released
• Reticulocyte response: begins in 3–5 days, peaks at 7–10 days

Symptoms (correlate with severity)

---

SECTION 6: QUICK COMPARISON TABLE — High-Yield for Exams

---

SECTION 7: MEMORY AIDS

• "FEAST" mnemonic for Pernicious anemia findings: Funicular myelosis (subacute combined degeneration), Endoscopy shows gastric atrophy, Antibodies (anti-parietal, anti-IF), Strawberry tongue (glossitis), Thrombocytopenia (all cell lines affected)
• Sickle cell vs. HbS trait: HbSS = disease; HbAS = trait (protective against P. falciparum — sickling in infected RBCs kills the parasite)
• Iron deficiency vs. ACD: Ferritin is the key — ↓ in IDA, ↑ in ACD (inflammation raises ferritin as an acute phase reactant)
• G6PD = "no NADPH, no GSH, no antioxidant" → oxidative stress → Heinz bodies → bite cells
• Thalassemia = "imbalance" — one chain missing, other chain precipitates. α-thal = chromosome 16, gene deletions. β-thal = chromosome 11, point mutations.

---

---

Anemia — Detailed MS1 Outline

Robbins, Cotran & Kumar — Pathologic Basis of Disease | Guyton & Hall — Medical Physiology

---

SECTION 1: DEFINITION & OVERVIEW

• ↓ Hematocrit (packed RBC volume / total blood volume)
• ↓ Hemoglobin concentration (g/dL)

"Anemia means deficiency of hemoglobin in the blood, which can be caused by too few RBCs or too little hemoglobin in the cells." — Guyton & Hall

---

SECTION 2: CLASSIFICATION

2A. By Mechanism (Robbins — Table 14.1)

2B. By Morphology (Peripheral Smear — Clinically Useful)

Key Red Cell Indices

---

SECTION 3: HEMOLYTIC ANEMIAS (Increased Destruction)

• ↓ Hb, ↓ Hematocrit
• ↑ Reticulocytes (compensatory BM response)
• ↑ Unconjugated (indirect) bilirubin → jaundice
• ↑ LDH (cell lysis marker)
• ↓ Haptoglobin (binds free Hb — gets consumed)
• Splenomegaly (from RBC trapping)

---

3A. HEREDITARY SPHEROCYTOSIS (HS)

Pathogenesis

• Autosomal dominant (AD) in most; some AR
• Mutations in RBC cytoskeletal proteins:
  • Ankyrin (most common), Spectrin (α or β), Band 3, Protein 4.2
• These proteins anchor the lipid bilayer to the underlying cytoskeleton
• Deficiency → membrane instability → RBC loses membrane fragments during repeated splenic passage (vesiculation)
• Surface area ↓ relative to volume → sphere shape (spherocyte) instead of biconcave disc
• Spherocytes are rigid → trapped in splenic sinusoids → destroyed by macrophages = extravascular hemolysis

"The RBCs are very small and spherical rather than biconcave discs. They cannot withstand compression forces because they do not have the normal loose, baglike membrane structure." — Guyton & Hall

Peripheral Smear

• Small, round, dark-staining spherocytes with no central pallor

Diagnosis

• Osmotic fragility test — spherocytes lyse in hypotonic saline more readily (↑ fragility)
• EMA binding test (flow cytometry) — modern, more sensitive
• Negative direct Coombs test (distinguishes from autoimmune HA)

Clinical Features

• Anemia (variable severity), Jaundice, Splenomegaly
• Pigment gallstones (excess bilirubin → calcium bilirubinate stones)
• Aplastic crisis — triggered by Parvovirus B19 (kills erythroid precursors → sudden severe anemia)
• Megaloblastic crisis — folate demand exceeds supply

Treatment

• Splenectomy — removes site of destruction → cures anemia (spherocytes persist on smear, but no longer destroyed)
• Folic acid supplementation

---

3B. G6PD DEFICIENCY

Pathogenesis

• X-linked recessive → mainly affects males
• G6PD = first enzyme of the HMP shunt → generates NADPH → keeps glutathione (GSH) in reduced form
• GSH = RBC's primary antioxidant (neutralizes H₂O₂ and superoxide)
• Without G6PD → NADPH depleted → GSH depleted → oxidative stress unchecked
• Oxidized hemoglobin denatures → forms Heinz bodies (precipitates on RBC membrane)
• Macrophages "bite out" Heinz bodies → bite cells / blister cells on smear
• Eventually → episodic hemolysis triggered by oxidative stressors

Triggers

Key Variants

Peripheral Smear During Crisis

• Bite cells / blister cells
• Heinz bodies (seen with crystal violet stain, not standard H&E)
• Polychromasia (reticulocytosis)

Diagnosis

• G6PD enzyme assay — best done after crisis (during crisis, deficient old cells are destroyed; only young cells with higher enzyme remain → may give false-normal result)

Clinical Features

• Between episodes: Completely normal
• During episode: Acute hemolytic anemia, dark urine (hemoglobinuria), jaundice, back/abdominal pain
• Self-limiting in G6PD A− (new young RBCs replace old ones); more severe in Mediterranean variant

Treatment

• Avoid triggers (primary prevention)
• Supportive care during crisis; transfusion if severe

---

3C. SICKLE CELL DISEASE (SCD)

Molecular Basis

• Autosomal recessive (codominant)
• Single point mutation in β-globin gene (chromosome 11): → Position 6: Glutamic acid → Valine → Normal HbA (α₂β₂) → HbS (α₂β^S₂)
• HbSS = sickle cell disease (severe)
• HbAS = sickle cell trait (asymptomatic, protective against P. falciparum malaria)

Mechanism of Sickling

1. Deoxygenation → HbS polymerizes into long rigid tactoids (fibers)
2. RBC distorts into a sickle/crescent shape
3. Initially reversible (re-oxygenation un-sickles); repeated episodes → irreversibly sickled cells (permanent membrane damage)
4. Sickled cells:
   • Are rigid → obstruct microvessels → vaso-occlusion → ischemia/infarction
   • Are fragile → destroyed by spleen → hemolysis

"The precipitated hemoglobin damages the cell membrane, so the cells become highly fragile, leading to serious anemia." — Guyton & Hall

Clinical Features

• Chronic hemolytic anemia (Hb 6–9 g/dL), jaundice, gallstones, splenomegaly (early)
• Aplastic crisis (Parvovirus B19)

Peripheral Smear

• Sickle cells (crescent-shaped), target cells
• Howell-Jolly bodies (nuclear remnants — normally removed by spleen; present after autosplenectomy)
• ↑ Reticulocytes

Diagnosis

• Hemoglobin electrophoresis (gold standard) — HbS band present, HbA absent in HbSS
• HPLC (newborn screening)
• Sickling test (sodium metabisulfite)

Treatment

• Hydroxyurea — ↑ HbF production (HbF inhibits HbS polymerization → ↓ sickling, ↓ crises)
• Penicillin prophylaxis (for asplenic patients)
• Vaccinations (pneumococcal, meningococcal, H. flu)
• Folic acid supplementation
• Exchange transfusion (acute chest syndrome, stroke)
• Bone marrow transplantation (curative)

---

3D. THALASSEMIA

---

β-Thalassemia

• Mutations in β-globin gene (chromosome 11) — mostly point mutations (>200 known)
• β⁰ = no β-chain produced; β⁺ = reduced β-chain produced
• ↓ β-globin → excess α-chains accumulate → precipitate as inclusions → damage RBC membrane → ineffective erythropoiesis (death of precursors in BM) + hemolysis
• Compensatory massive erythropoiesis → bone marrow expansion → skeletal deformities

• Severe hemolytic anemia appearing at 6 months (HbF → HbA switch)
• Massive hepatosplenomegaly (extramedullary hematopoiesis)
• "Crew-cut" skull X-ray (expanded diploe — perpendicular trabeculae)
• Chipmunk facies (maxillary bone overgrowth)
• Growth retardation
• Iron overload (from transfusions + ↑ GI absorption) → hemosiderosis → heart failure, cirrhosis, endocrine failure (the main cause of death)
• Lab: ↑ HbF, absent/↓ HbA, ↑ HbA₂

---

α-Thalassemia

• Deletions in α-globin genes (chromosome 16) — normal = 4 α-genes

---

3E. AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

---

3F. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

• Acquired mutation in PIG-A gene → loss of GPI-anchor proteins (CD55, CD59)
• CD55/CD59 normally protect RBCs from complement attack
• Without them → complement destroys RBCs → intravascular hemolysis
• Classic triad: hemolytic anemia + thrombosis (unusual sites: hepatic vein) + cytopenias
• Hemoglobinuria worst in morning (acidosis during sleep → complement activation)
• Diagnosis: Flow cytometry (loss of CD55/CD59)
• Treatment: Eculizumab (anti-C5 complement inhibitor)

---

SECTION 4: ANEMIAS OF DIMINISHED ERYTHROPOIESIS

4A. IRON DEFICIENCY ANEMIA — Most common anemia worldwide

Iron Metabolism

• Absorbed in duodenum/proximal jejunum (needs acidic pH; enhanced by vitamin C; inhibited by phytates, tea)
• Stored as ferritin (soluble) and hemosiderin (insoluble) in liver, spleen, marrow
• Transported by transferrin in plasma

Causes

⚠️ "An alert clinician investigating unexplained iron deficiency anemia occasionally discovers an occult bleeding source such as cancer and thereby saves a life." — Robbins & Cotran

Lab Findings

Stages of Depletion

1. Pre-latent: Stores depleted (↓ ferritin), normal Hb
2. Latent: ↓ serum iron, ↑ TIBC, normal Hb
3. IDA: Microcytic hypochromic anemia appears

Clinical Features

• Fatigue, pallor, exertional dyspnea
• Pica — craving for non-food items (ice, clay)
• Koilonychia — spoon-shaped nails
• Angular stomatitis, atrophic glossitis
• Plummer-Vinson syndrome — IDA + esophageal webs + dysphagia (→ ↑ risk esophageal carcinoma)

Treatment

• Find and treat underlying cause
• Oral ferrous sulfate for 3–6 months (continue 3 months after Hb normalizes to replenish stores)
• IV iron (malabsorption, intolerance, severe)
• Reticulocyte response in 5–10 days = confirms diagnosis

---

4B. MEGALOBLASTIC ANEMIA (Vitamin B12 / Folate Deficiency)

Core Concept

"The RBCs grow too large, with odd shapes, and are called megaloblasts... the cells are mostly oversized, have bizarre shapes, and fragile membranes." — Guyton & Hall

Vitamin B12 Deficiency

• Autoimmune destruction of parietal cells
• Anti-parietal cell antibodies (destroy the cells); anti-IF antibodies (block B12-IF binding)
• Associated with Hashimoto's thyroiditis, T1DM
• ↑ risk of gastric adenocarcinoma

• Subacute combined degeneration of the spinal cord — degeneration of dorsal columns (vibration/proprioception loss) + lateral corticospinal tracts (upper motor neuron signs) + peripheral neuropathy
• Neurological damage progresses even if hematologic anemia is "corrected" by giving folate alone → dangerous

Folate Deficiency

• Poor diet (alcoholics, elderly, overcooking vegetables)
• ↑ Demand (pregnancy, hemolytic anemia, rapid growth)
• Malabsorption (celiac disease)
• Drugs: Methotrexate, trimethoprim, phenytoin (folate antagonists)

⚠️ Folate in pregnancy: Deficiency → neural tube defects (spina bifida, anencephaly). Supplement from before conception.

Lab Findings (Both B12 and Folate)

Treatment

• B12: IM cyanocobalamin (oral ineffective in pernicious anemia/malabsorption)
• Folate: Oral folic acid
• ⚠️ Never give folate alone if B12 deficiency suspected — corrects blood picture but neurological damage continues

---

4C. APLASTIC ANEMIA

Causes

"Exposure to high-dose radiation or chemotherapy... damage stem cells of the bone marrow... insecticides or benzene in gasoline may cause the same effect." — Guyton & Hall

Lab Findings

• Pancytopenia
• Hypocellular bone marrow with fatty replacement (> 70% fat on biopsy) — diagnostic
• ↓ Reticulocytes (production failure)
• Normal RBC morphology

Clinical Features

• Anemia symptoms (fatigue, pallor)
• Infections (from neutropenia — most life-threatening)
• Bleeding (thrombocytopenia — petechiae, ecchymoses)

Treatment

• Severe + young with matched donor: Bone marrow transplantation (curative)
• Severe without donor: Immunosuppression (anti-thymocyte globulin + cyclosporine + eltrombopag)
• Supportive: transfusions, G-CSF

---

4D. ANEMIA OF CHRONIC DISEASE (ACD)

Pathogenesis

• Chronic infection / autoimmune disease / cancer → chronic inflammation → IL-6 → ↑ hepcidin (liver-derived)
• Hepcidin degrades ferroportin (iron exporter on macrophages and gut enterocytes)
• Result: iron trapped in macrophage stores, ↓ GI iron absorption → functional iron deficiency (iron present but not accessible for erythropoiesis)
• Also: ↓ EPO response, ↓ RBC lifespan

Key Lab Comparison

"Storage iron in the bone marrow and serum ferritin are increased [in ACD], in contrast to iron deficiency anemia." — Robbins & Cotran

Treatment

• Treat underlying disease
• ESAs (erythropoietin-stimulating agents) in CKD
• IV iron if also functionally iron-depleted

---

SECTION 5: PHYSIOLOGICAL EFFECTS OF ANEMIA — Guyton & Hall

Cardiovascular Compensation

• ↓ Blood viscosity → ↓ peripheral resistance → ↑ cardiac output (↑ HR + ↑ SV)
• Chronic severe anemia → high-output state → heart failure
• Vasodilation from tissue hypoxia-induced local mediators

O₂ Delivery Compensation

• ↑ 2,3-BPG (DPG) in RBCs → right-shifts O₂-Hb dissociation curve → Hb releases O₂ more easily to tissues
• ↑ O₂ extraction fraction per unit blood

Erythropoietin Response

• Kidney peritubular cells sense ↓ O₂ → ↑ EPO → BM → ↑ erythroid progenitor proliferation → ↑ reticulocyte release
• Reticulocyte response begins in 3–5 days, peaks at 7–10 days

Symptoms by Severity

---

SECTION 6: MASTER COMPARISON TABLE

---

SECTION 7: MEMORY AIDS

---

---

Membrane Potential — Physiology (MS Level)

Guyton and Hall Textbook of Medical Physiology, Chapters 5 & 6

---

SECTION 1: BASIC CONCEPTS — What Is a Membrane Potential?

• Measured as: potential inside the cell relative to outside
• At rest: −70 mV in a large nerve fiber (inside is negative relative to outside)
• This negativity is not just passively sitting there — it is actively maintained by ion transport mechanisms

"The potential inside the fiber is 70 mV more negative than the potential in the extracellular fluid on the outside of the fiber." — Guyton & Hall

1. There are unequal ion concentrations on the two sides of the membrane
2. The membrane has selective permeability — it lets some ions pass more easily than others
3. The Na⁺-K⁺ pump actively maintains the concentration gradients

---

SECTION 2: ION CONCENTRATIONS ACROSS THE MEMBRANE

---

SECTION 3: DIFFUSION POTENTIALS AND THE NERNST EQUATION

3A. Diffusion Potential — The Core Concept

• K⁺ diffuses outward (high inside → low outside) → carries positive charges out → inside becomes negative → −94 mV (Nernst potential for K⁺)
• Na⁺ diffuses inward (high outside → low inside) → carries positive charges in → inside becomes positive → +61 mV (Nernst potential for Na⁺)

3B. The Nernst Equation

• EMF = electromotive force (the Nernst potential)
• z = electrical charge of the ion (+1 for Na⁺/K⁺, +2 for Ca²⁺, −1 for Cl⁻)
• 61 = constant at 37°C (body temperature)

• K⁺: 61/1 × log(140/4) = 61 × log(35) = 61 × 1.544 = −94 mV (inside negative because K⁺ leaves)
• Na⁺: 61/1 × log(14/142) = 61 × log(0.1) = 61 × (−1) = −61 mV; but since Na⁺ enters, polarity is +61 mV inside

Remember: if the ion is positive and diffuses OUT, inside becomes negative. If it diffuses IN, inside becomes positive.

3C. The Goldman-Hodgkin-Katz (GHK) Equation

• At rest: membrane is ~100x more permeable to K⁺ than Na⁺ → K⁺ dominates → resting potential (~−70 mV) is closer to K⁺ Nernst potential (−94 mV) than to Na⁺ Nernst potential (+61 mV)
• During action potential: membrane becomes transiently ~500–1000x more permeable to Na⁺ → potential swings toward +61 mV → the overshoot

---

SECTION 4: THE Na⁺-K⁺ ATPase PUMP

Mechanism

• Pumps 3 Na⁺ OUT and 2 K⁺ IN per ATP hydrolyzed
• Uses 1 ATP molecule per cycle
• The protein has two conformational states (E1 and E2) — binds Na⁺ intracellularly and K⁺ extracellularly

Two Roles of the Na⁺-K⁺ Pump

"This is an electrogenic pump because three Na⁺ ions are pumped to the outside for each two K⁺ ions to the inside, leaving a net deficit of positive ions on the inside." — Guyton & Hall

K⁺ Leak Channels

• Always open at rest (also called tandem pore domain or background K⁺ channels)
• Allow K⁺ to continuously diffuse outward down its concentration gradient
• This ongoing K⁺ leak is the primary reason the resting membrane potential is negative
• Membrane is ~100x more permeable to K⁺ than Na⁺ at rest

---

SECTION 5: ORIGIN OF THE RESTING MEMBRANE POTENTIAL

Contribution 1 — K⁺ Diffusion Potential (dominant)

• High intracellular K⁺ → K⁺ leaks out through K⁺ leak channels
• Carries positive charges out → inside becomes negative
• Alone would produce −94 mV (the K⁺ Nernst potential)

Contribution 2 — Na⁺ Leak (opposing)

• Small but constant inward Na⁺ leak through K⁺ leak channels
• Brings positive charges in → partially offsets the negative potential
• Pulls potential up from −94 mV toward zero

Contribution 3 — Na⁺-K⁺ Pump (electrogenic, minor)

• Direct electrogenic contribution of ~−4 mV
• Major role is maintaining the ion gradients, not the direct electrogenic effect

• K⁺ contribution alone: −94 mV
• Na⁺ leak partially offsets: pulls toward +61 mV
• Final resting potential: −70 mV (a weighted average based on relative permeabilities)

Summary: resting potential = largely determined by K⁺ concentration gradient + K⁺ leak channels, slightly reduced in magnitude by background Na⁺ leak.

---

SECTION 6: THE ACTION POTENTIAL

6A. Definition

6B. The Action Potential Curve — Five Stages

6C. Conductance Changes During the Action Potential

• At rest: K⁺ conductance 50–100x > Na⁺ conductance
• At depolarization onset: Na⁺ conductance increases up to 5000-fold instantaneously
• Na⁺ channels then inactivate within a fraction of a millisecond
• K⁺ channels open slowly (~0.5 ms after Na⁺ channels) and remain open longer
• Na⁺/K⁺ conductance ratio: >1000-fold increase during early action potential → drives overshoot

---

SECTION 7: VOLTAGE-GATED ION CHANNELS IN DETAIL

7A. Voltage-Gated Na⁺ Channel — Three States

• Activation gate (m-gate): near the outer face — opens with depolarization
• Inactivation gate (h-gate): near the inner face — closes with slight delay after depolarization

Key point: The inactivated state is different from the resting closed state. The inactivation gate must be "reset" — this requires the membrane to repolarize. This is why the channel cannot immediately be re-opened — it underlies the refractory period.

7B. Voltage-Gated K⁺ Channel — Two States (Simpler)

• Closed at rest
• Opens slowly when membrane depolarizes (delayed ~0.5 ms after Na⁺ channels)
• Closes slowly when membrane repolarizes → explains why hyperpolarization (undershoot) occurs
• Has only one gate (activation gate; no separate inactivation gate)

---

SECTION 8: THRESHOLD AND ALL-OR-NONE LAW

Threshold Potential

• The membrane potential must be depolarized to approximately −55 mV to trigger an action potential
• That means the membrane needs to be depolarized by ~15–20 mV from resting (from −70 to −55 mV)
• Below threshold: Graded, local, non-propagating potential (decremental)
• At/above threshold: Explosive positive feedback → full action potential fires

Positive Feedback Cycle (Hodgkin Cycle)

"This process is a positive-feedback cycle that, once the feedback is strong enough, continues until all the voltage-gated sodium channels have become activated." — Guyton & Hall

All-or-None Law

---

SECTION 9: PROPAGATION OF THE ACTION POTENTIAL

1. Na⁺ enters at the excited zone → positive charges flow inward
2. Positive charges spread laterally along the inside of the axon
3. This depolarizes adjacent membrane to threshold
4. New Na⁺ channels open in the adjacent zone → action potential fires there
5. Process continues in both directions

Propagation Velocity

---

SECTION 10: SALTATORY CONDUCTION IN MYELINATED FIBERS

• Myelin sheath = layers of lipid-rich membrane wound around the axon
• Acts as an excellent electrical insulator — prevents ion leakage through internodal segments
• Nodes of Ranvier = small gaps (~1–2 µm) in the myelin sheath where Na⁺ channels are densely concentrated
• Action potential jumps from node to node (saltatory = "to jump" in Latin)

1. Faster conduction (action potential skips long internodal segments)
2. Energy efficient — Na⁺/K⁺ pump only needs to restore ions at nodes, not along the entire axon
3. Allows large, fast axons in a compact space

---

SECTION 11: REFRACTORY PERIODS

Absolute Refractory Period (ARP)

• Lasts ~1 ms after an action potential in large nerve fibers
• During this time, no stimulus, however strong, can trigger another action potential
• Caused by: Na⁺ channel inactivation gates are closed — channels are in the inactivated state
• Cannot fire until the inactivation gate resets (requires repolarization)

Relative Refractory Period (RRP)

• Follows the ARP, lasts a few more milliseconds
• Some Na⁺ channels have recovered (reset to resting state), but K⁺ channels are still open → membrane is hyperpolarized
• A stronger-than-normal stimulus can trigger an action potential
• The resulting action potential will be slightly smaller than normal

• Large nerve fibers: up to 1000 impulses/second
• Most CNS neurons: much lower rates due to longer refractory periods

---

SECTION 12: SPECIAL MEMBRANE POTENTIALS IN OTHER TISSUES

Cardiac Muscle (Brief Comparison)

1. Prolonged Ca²⁺ influx through slow voltage-gated L-type Ca²⁺ channels (depolarizing)
2. Simultaneous K⁺ channels are initially suppressed (preventing immediate repolarization)
3. Eventually delayed rectifier K⁺ channels open → repolarization

Smooth Muscle

• Resting potential: −50 to −60 mV (less negative than skeletal/cardiac)
• Some smooth muscle generates spontaneous pacemaker potentials (unstable resting potential)
• Action potentials may use Ca²⁺ as the primary depolarizing ion (not Na⁺)
• Multi-unit smooth muscle may depolarize without action potentials (graded potentials only)

---

SECTION 13: GRADED POTENTIALS vs. ACTION POTENTIALS

Graded potentials summate at the axon hillock — if the summed depolarization reaches threshold (−55 mV), an action potential fires.

---

SECTION 14: CLINICAL AND PHARMACOLOGICAL RELEVANCE

---

SECTION 15: SUMMARY — KEY VALUES TO MEMORIZE

---

SECTION 16: MEMORY AIDS

---